Document is current
Any future updates will be listed below
-
Authors
Danz, Hillary
Dauner, Allison
Sharma, Shraddha
Babiceanu, Mihaela
Clark, Nicholas
Ontiveros, Robert Jordan
Amezquita, Robert
Zhilin-Roth, Alisa
Reyes, Eric
Khoo, Catherine
Gilbert, Kara
Nadkarni, Janhavi
Chaudhary, Omkar
Lee, Christina
Kume, Ana
Bahadoran, Azadeh
Motwani, Mona
Lu, Bin
Zong, Wei
Kettring, Andrew
Shumate, Alex
Karve, Shrirang
Dias, Anusha
Wu, Monica
Gu, Xiaobo
Yan, Yanhua
Anderson, Daniel G.
Schanen, Brian
Chivukula, Sudha https://orcid.org/0000-0002-1832-1465
DeRosa, Frank
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 24 August 2025
First Online: 29 September 2025
Competing interests
: The research is funded by Sanofi. Hillary Danz, Allison Dauner, Shraddha Sharma, Mihaela Babiceanu, Nicholas Clark, Robert Jordan Ontiveros, Robert Amezquita, Mona Motwani, Bin Lu, Alisa Zhilin-Roth, Eric Reyes, Catherine Khoo, Ana Kume, Azadeh Bahadoran, Janhavi Nadkarni, Omkar Chaudhary, Christina Lee, Wei Zong, Andrew Kettring, Alex Shumate, Shrirang Karve, Anusha Dias, Monica Wu, Xiaobo Gu, Yanhua Yan, Frank DeRosa, Brian Schanen and, Sudha Chivukula are employees of Sanofi and may hold stock in the company. Daniel Griffith Anderson receives research funding from Sanofi, is a Founder of oRNA Tx and receives compensation and equity from Combined Therapeutics.
